List of Tables
Table 1. Global Desloratadine Tablets Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Table 2. Global Desloratadine Tablets Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Table 3. Global Desloratadine Tablets Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 4. Global Desloratadine Tablets Revenue by Region (2020-2025) & (US$ Million)
Table 5. Global Desloratadine Tablets Revenue by Region (2026-2031) & (US$ Million)
Table 6. Global Desloratadine Tablets Sales Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (K Units)
Table 7. Global Desloratadine Tablets Sales by Region (2020-2025) & (K Units)
Table 8. Global Desloratadine Tablets Sales by Region (2026-2031) & (K Units)
Table 9. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 10. Global Desloratadine Tablets Sales by Manufacturers (2020-2025) & (K Units)
Table 11. Global Desloratadine Tablets Sales Share by Manufacturers (2020-2025)
Table 12. Global Desloratadine Tablets Revenue by Manufacturers (2020-2025) & (US$ Million)
Table 13. Global Desloratadine Tablets Revenue Market Share by Manufacturers (2020-2025)
Table 14. Global Key Manufacturers’Ranking Shift (2023 vs. 2024) (Based on Revenue)
Table 15. Global Desloratadine Tablets by Manufacturer Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Desloratadine Tablets as of 2024)
Table 16. Global Desloratadine Tablets Average Gross Margin (%) by Manufacturer (2020 VS 2024)
Table 17. Global Desloratadine Tablets Average Selling Price (ASP) by Manufacturers (2020-2025) & (US$/Unit)
Table 18. Key Manufacturers Desloratadine Tablets Manufacturing Base and Headquarters
Table 19. Global Desloratadine Tablets Market Concentration Ratio (CR5 and HHI)
Table 20. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
Table 21. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
Table 22. Global Desloratadine Tablets Sales by Type (2020-2025) & (K Units)
Table 23. Global Desloratadine Tablets Sales by Type (2026-2031) & (K Units)
Table 24. Global Desloratadine Tablets Revenue by Type (2020-2025) & (US$ Million)
Table 25. Global Desloratadine Tablets Revenue by Type (2026-2031) & (US$ Million)
Table 26. Global Desloratadine Tablets ASP by Type (2020-2031) & (US$/Unit)
Table 27. Technical Specifications by Key Product Type
Table 28. Global Desloratadine Tablets Sales by Application (2020-2025) & (K Units)
Table 29. Global Desloratadine Tablets Sales by Application (2026-2031) & (K Units)
Table 30. Desloratadine Tablets High-Growth Sectors Demand CAGR (2024-2031)
Table 31. Global Desloratadine Tablets Revenue by Application (2020-2025) & (US$ Million)
Table 32. Global Desloratadine Tablets Revenue by Application (2026-2031) & (US$ Million)
Table 33. Global Desloratadine Tablets ASP by Application (2020-2031) & (US$/Unit)
Table 34. Top Customers by Region
Table 35. Top Customers by Application
Table 36. North America Desloratadine Tablets Growth Accelerators and Market Barriers
Table 37. North America Desloratadine Tablets Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 38. North America Desloratadine Tablets Sales (K Units) by Country (2020 VS 2024 VS 2031)
Table 39. Europe Desloratadine Tablets Growth Accelerators and Market Barriers
Table 40. Europe Desloratadine Tablets Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Europe Desloratadine Tablets Sales (K Units) by Country (2020 VS 2024 VS 2031)
Table 42. Asia-Pacific Desloratadine Tablets Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 43. Asia-Pacific Desloratadine Tablets Sales (K Units) by Country (2020 VS 2024 VS 2031)
Table 44. Asia-Pacific Desloratadine Tablets Growth Accelerators and Market Barriers
Table 45. Southeast Asia Desloratadine Tablets Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Central and South America Desloratadine Tablets Investment Opportunities and Key Challenges
Table 47. Central and South America Desloratadine Tablets Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 48. Middle East and Africa Desloratadine Tablets Investment Opportunities and Key Challenges
Table 49. Middle East and Africa Desloratadine Tablets Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 50. Sun Pharmaceutical Industries Corporation Information
Table 51. Sun Pharmaceutical Industries Description and Major Businesses
Table 52. Sun Pharmaceutical Industries Product Models, Descriptions and Specifications
Table 53. Sun Pharmaceutical Industries Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 54. Sun Pharmaceutical Industries Sales Value Proportion by Product in 2024
Table 55. Sun Pharmaceutical Industries Sales Value Proportion by Application in 2024
Table 56. Sun Pharmaceutical Industries Sales Value Proportion by Geographic Area in 2024
Table 57. Sun Pharmaceutical Industries Desloratadine Tablets SWOT Analysis
Table 58. Sun Pharmaceutical Industries Recent Developments
Table 59. Teva Pharmaceutical Industries Corporation Information
Table 60. Teva Pharmaceutical Industries Description and Major Businesses
Table 61. Teva Pharmaceutical Industries Product Models, Descriptions and Specifications
Table 62. Teva Pharmaceutical Industries Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 63. Teva Pharmaceutical Industries Sales Value Proportion by Product in 2024
Table 64. Teva Pharmaceutical Industries Sales Value Proportion by Application in 2024
Table 65. Teva Pharmaceutical Industries Sales Value Proportion by Geographic Area in 2024
Table 66. Teva Pharmaceutical Industries Desloratadine Tablets SWOT Analysis
Table 67. Teva Pharmaceutical Industries Recent Developments
Table 68. Mylan Corporation Information
Table 69. Mylan Description and Major Businesses
Table 70. Mylan Product Models, Descriptions and Specifications
Table 71. Mylan Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 72. Mylan Sales Value Proportion by Product in 2024
Table 73. Mylan Sales Value Proportion by Application in 2024
Table 74. Mylan Sales Value Proportion by Geographic Area in 2024
Table 75. Mylan Desloratadine Tablets SWOT Analysis
Table 76. Mylan Recent Developments
Table 77. Glenmark Pharmaceuticals Corporation Information
Table 78. Glenmark Pharmaceuticals Description and Major Businesses
Table 79. Glenmark Pharmaceuticals Product Models, Descriptions and Specifications
Table 80. Glenmark Pharmaceuticals Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 81. Glenmark Pharmaceuticals Sales Value Proportion by Product in 2024
Table 82. Glenmark Pharmaceuticals Sales Value Proportion by Application in 2024
Table 83. Glenmark Pharmaceuticals Sales Value Proportion by Geographic Area in 2024
Table 84. Glenmark Pharmaceuticals Desloratadine Tablets SWOT Analysis
Table 85. Glenmark Pharmaceuticals Recent Developments
Table 86. Torrent Pharmaceuticals Corporation Information
Table 87. Torrent Pharmaceuticals Description and Major Businesses
Table 88. Torrent Pharmaceuticals Product Models, Descriptions and Specifications
Table 89. Torrent Pharmaceuticals Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 90. Torrent Pharmaceuticals Sales Value Proportion by Product in 2024
Table 91. Torrent Pharmaceuticals Sales Value Proportion by Application in 2024
Table 92. Torrent Pharmaceuticals Sales Value Proportion by Geographic Area in 2024
Table 93. Torrent Pharmaceuticals Desloratadine Tablets SWOT Analysis
Table 94. Torrent Pharmaceuticals Recent Developments
Table 95. Apotex Corporation Information
Table 96. Apotex Description and Major Businesses
Table 97. Apotex Product Models, Descriptions and Specifications
Table 98. Apotex Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 99. Apotex Recent Developments
Table 100. Dr. Reddy's Laboratories Corporation Information
Table 101. Dr. Reddy's Laboratories Description and Major Businesses
Table 102. Dr. Reddy's Laboratories Product Models, Descriptions and Specifications
Table 103. Dr. Reddy's Laboratories Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 104. Dr. Reddy's Laboratories Recent Developments
Table 105. Sandoz International GmbH Corporation Information
Table 106. Sandoz International GmbH Description and Major Businesses
Table 107. Sandoz International GmbH Product Models, Descriptions and Specifications
Table 108. Sandoz International GmbH Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 109. Sandoz International GmbH Recent Developments
Table 110. Perrigo Company plc Corporation Information
Table 111. Perrigo Company plc Description and Major Businesses
Table 112. Perrigo Company plc Product Models, Descriptions and Specifications
Table 113. Perrigo Company plc Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 114. Perrigo Company plc Recent Developments
Table 115. Yangtze River Pharmaceutical Group Corporation Information
Table 116. Yangtze River Pharmaceutical Group Description and Major Businesses
Table 117. Yangtze River Pharmaceutical Group Product Models, Descriptions and Specifications
Table 118. Yangtze River Pharmaceutical Group Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 119. Yangtze River Pharmaceutical Group Recent Developments
Table 120. Shenzhen Salubris Pharmaceuticals Corporation Information
Table 121. Shenzhen Salubris Pharmaceuticals Description and Major Businesses
Table 122. Shenzhen Salubris Pharmaceuticals Product Models, Descriptions and Specifications
Table 123. Shenzhen Salubris Pharmaceuticals Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 124. Shenzhen Salubris Pharmaceuticals Recent Developments
Table 125. Poly Pharm Corporation Information
Table 126. Poly Pharm Description and Major Businesses
Table 127. Poly Pharm Product Models, Descriptions and Specifications
Table 128. Poly Pharm Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 129. Poly Pharm Recent Developments
Table 130. Zhejiang China Resources Sanjiu Zhongyi Pharmaceutical Corporation Information
Table 131. Zhejiang China Resources Sanjiu Zhongyi Pharmaceutical Description and Major Businesses
Table 132. Zhejiang China Resources Sanjiu Zhongyi Pharmaceutical Product Models, Descriptions and Specifications
Table 133. Zhejiang China Resources Sanjiu Zhongyi Pharmaceutical Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 134. Zhejiang China Resources Sanjiu Zhongyi Pharmaceutical Recent Developments
Table 135. Organon Pharma Corporation Information
Table 136. Organon Pharma Description and Major Businesses
Table 137. Organon Pharma Product Models, Descriptions and Specifications
Table 138. Organon Pharma Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 139. Organon Pharma Recent Developments
Table 140. Yingtai Pharma Corporation Information
Table 141. Yingtai Pharma Description and Major Businesses
Table 142. Yingtai Pharma Product Models, Descriptions and Specifications
Table 143. Yingtai Pharma Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 144. Yingtai Pharma Recent Developments
Table 145. Sinopharm Group Pharmaceuticals Corporation Information
Table 146. Sinopharm Group Pharmaceuticals Description and Major Businesses
Table 147. Sinopharm Group Pharmaceuticals Product Models, Descriptions and Specifications
Table 148. Sinopharm Group Pharmaceuticals Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 149. Sinopharm Group Pharmaceuticals Recent Developments
Table 150. Guangdong Jiuming pharmaceutical Corporation Information
Table 151. Guangdong Jiuming pharmaceutical Description and Major Businesses
Table 152. Guangdong Jiuming pharmaceutical Product Models, Descriptions and Specifications
Table 153. Guangdong Jiuming pharmaceutical Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 154. Guangdong Jiuming pharmaceutical Recent Developments
Table 155. FangYuan Pharmaceutical Corporation Information
Table 156. FangYuan Pharmaceutical Description and Major Businesses
Table 157. FangYuan Pharmaceutical Product Models, Descriptions and Specifications
Table 158. FangYuan Pharmaceutical Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 159. FangYuan Pharmaceutical Recent Developments
Table 160. Key Raw Materials Distribution
Table 161. Raw Materials Key Suppliers
Table 162. Critical Raw Material Supplier Concentration (2024) & Risk Index
Table 163. Milestones in Production Technology Evolution
Table 164. Distributors List
Table 165. Market Trends and Market Evolution
Table 166. Market Drivers and Opportunities
Table 167. Market Challenges, Risks, and Restraints
Table 168. Research Programs/Design for This Report
Table 169. Key Data Information from Secondary Sources
Table 170. Key Data Information from Primary Sources
List of Figures
Figure 1. Desloratadine Tablets Product Picture
Figure 2. Global Desloratadine Tablets Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Figure 3. Ordinary Tablets Product Picture
Figure 4. Dispersible Tablets Product Picture
Figure 5. Other Product Picture
Figure 6. Global Desloratadine Tablets Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Figure 7. Hospital and Clinic
Figure 8. Specialist Medical Centre
Figure 9. Retail Pharmacies
Figure 10. Other
Figure 11. Desloratadine Tablets Report Years Considered
Figure 12. Global Desloratadine Tablets Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 13. Global Desloratadine Tablets Revenue (2020-2031) & (US$ Million)
Figure 14. Global Desloratadine Tablets Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Figure 15. Global Desloratadine Tablets Revenue Market Share by Region (2020-2031)
Figure 16. Global Desloratadine Tablets Sales (2020-2031) & (K Units)
Figure 17. Global Desloratadine Tablets Sales (CAGR) by Region (2020-2031) (K Units)
Figure 18. Global Desloratadine Tablets Sales Market Share by Region (2020-2031)
Figure 19. Top 5 and Top 10 Manufacturers Desloratadine Tablets Sales Volume Market Share in 2024
Figure 20. Global Desloratadine Tablets Revenue Market Share Ranking (2024)
Figure 21. Tier Distribution by Revenue Contribution (2020 VS 2024)
Figure 22. Ordinary Tablets Revenue Market Share by Manufacturer in 2024
Figure 23. Dispersible Tablets Revenue Market Share by Manufacturer in 2024
Figure 24. Other Revenue Market Share by Manufacturer in 2024
Figure 25. Global Desloratadine Tablets Sales Market Share by Type (2020-2031)
Figure 26. Global Desloratadine Tablets Revenue Market Share by Type (2020-2031)
Figure 27. Global Desloratadine Tablets Sales Market Share by Application (2020-2031)
Figure 28. Global Desloratadine Tablets Revenue Market Share by Application (2020-2031)
Figure 29. North America Desloratadine Tablets Sales YoY (2020-2031) & (K Units)
Figure 30. North America Desloratadine Tablets Revenue YoY (2020-2031) & (US$ Million)
Figure 31. North America Top 5 Manufacturers Desloratadine Tablets Sales Revenue (US$ Million) in 2024
Figure 32. North America Desloratadine Tablets Sales Volume (K Units) by Type (2020- 2031)
Figure 33. North America Desloratadine Tablets Sales Revenue (US$ Million) by Type (2020 - 2031)
Figure 34. North America Desloratadine Tablets Sales Volume (K Units) by Application (2020-2031)
Figure 35. North America Desloratadine Tablets Sales Revenue (US$ Million) by Application (2020-2031)
Figure 36. US Desloratadine Tablets Revenue (2020-2031) & (US$ Million)
Figure 37. Canada Desloratadine Tablets Revenue (2020-2031) & (US$ Million)
Figure 38. Mexico Desloratadine Tablets Revenue (2020-2031) & (US$ Million)
Figure 39. Europe Desloratadine Tablets Sales YoY (2020-2031) & (K Units)
Figure 40. Europe Desloratadine Tablets Revenue YoY (2020-2031) & (US$ Million)
Figure 41. Europe Top 5 Manufacturers Desloratadine Tablets Sales Revenue (US$ Million) in 2024
Figure 42. Europe Desloratadine Tablets Sales Volume (K Units) by Type (2020-2031)
Figure 43. Europe Desloratadine Tablets Sales Revenue (US$ Million) by Type (2020-2031)
Figure 44. Europe Desloratadine Tablets Sales Volume (K Units) by Application (2020-2031)
Figure 45. Europe Desloratadine Tablets Sales Revenue (US$ Million) by Application (2020-2031)
Figure 46. Germany Desloratadine Tablets Revenue (2020-2031) & (US$ Million)
Figure 47. France Desloratadine Tablets Revenue (2020-2031) & (US$ Million)
Figure 48. U.K. Desloratadine Tablets Revenue (2020-2031) & (US$ Million)
Figure 49. Italy Desloratadine Tablets Revenue (2020-2031) & (US$ Million)
Figure 50. Russia Desloratadine Tablets Revenue (2020-2031) & (US$ Million)
Figure 51. Asia-Pacific Desloratadine Tablets Sales YoY (2020-2031) & (K Units)
Figure 52. Asia-Pacific Desloratadine Tablets Revenue YoY (2020-2031) & (US$ Million)
Figure 53. Asia-Pacific Top 8 Manufacturers Desloratadine Tablets Sales Revenue (US$ Million) in 2024
Figure 54. Asia-Pacific Desloratadine Tablets Sales Volume (K Units) by Type (2020- 2031)
Figure 55. Asia-Pacific Desloratadine Tablets Sales Revenue (US$ Million) by Type (2020- 2031)
Figure 56. Asia-Pacific Desloratadine Tablets Sales Volume (K Units) by Application (2020-2031)
Figure 57. Asia-Pacific Desloratadine Tablets Sales Revenue (US$ Million) by Application (2020-2031)
Figure 58. Indonesia Desloratadine Tablets Revenue (2020-2031) & (US$ Million)
Figure 59. Japan Desloratadine Tablets Revenue (2020-2031) & (US$ Million)
Figure 60. South Korea Desloratadine Tablets Revenue (2020-2031) & (US$ Million)
Figure 61. China Taiwan Desloratadine Tablets Revenue (2020-2031) & (US$ Million)
Figure 62. India Desloratadine Tablets Revenue (2020-2031) & (US$ Million)
Figure 63. Central and South America Desloratadine Tablets Sales YoY (2020-2031) & (K Units)
Figure 64. Central and South America Desloratadine Tablets Revenue YoY (2020-2031) & (US$ Million)
Figure 65. Central and South America Top 5 Manufacturers Desloratadine Tablets Sales Revenue (US$ Million) in 2024
Figure 66. Central and South America Desloratadine Tablets Sales Volume (K Units) by Type (2021-2031)
Figure 67. Central and South America Desloratadine Tablets Sales Revenue (US$ Million) by Type (2020-2031)
Figure 68. Central and South America Desloratadine Tablets Sales Volume (K Units) by Application (2020-2031)
Figure 69. Central and South America Desloratadine Tablets Sales Revenue (US$ Million) by Application (2020-2031)
Figure 70. Brazil Desloratadine Tablets Revenue (2020-2025) & (US$ Million)
Figure 71. Argentina Desloratadine Tablets Revenue (2020-2025) & (US$ Million)
Figure 72. Middle East, and Africa Desloratadine Tablets Sales YoY (2020-2031) & (K Units)
Figure 73. Middle East and Africa Desloratadine Tablets Revenue YoY (2020-2031) & (US$ Million)
Figure 74. Middle East and Africa Top 5 Manufacturers Desloratadine Tablets Sales Revenue (US$ Million) in 2024
Figure 75. Middle East and Africa Desloratadine Tablets Sales Volume (K Units) by Type (2021-2031)
Figure 76. South America Desloratadine Tablets Sales Revenue (US$ Million) by Type (2020-2031)
Figure 77. Middle East and Africa Desloratadine Tablets Sales Volume (K Units) by Application (2020-2031)
Figure 78. Middle East and Africa Desloratadine Tablets Sales Revenue (US$ Million) by Application (2020-2031)
Figure 79. GCC Countries Desloratadine Tablets Revenue (2020-2025) & (US$ Million)
Figure 80. Turkey Desloratadine Tablets Revenue (2020-2025) & (US$ Million)
Figure 81. Egypt Desloratadine Tablets Revenue (2020-2025) & (US$ Million)
Figure 82. South Africa Desloratadine Tablets Revenue (2020-2025) & (US$ Million)
Figure 83. Desloratadine Tablets Industry Chain Mapping
Figure 84. Regional Desloratadine Tablets Manufacturing Base Distribution (%)
Figure 85. Global Desloratadine Tablets Production Market Share by Region (2020-2031)
Figure 86. Desloratadine Tablets Production Process
Figure 87. Regional Desloratadine Tablets Production Cost Structure
Figure 88. Channels of Distribution (Direct Vs Distribution)
Figure 89. Bottom-up and Top-down Approaches for This Report
Figure 90. Data Triangulation
Figure 91. Key Executives Interviewed
